Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biomedica ; 42(3): 445-449, 2022 09 02.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-36122284

RESUMO

Neuroleptic malignant syndrome is a rare and potentially fatal clinical condition frequently associated with the use of antipsychotics. In the literature, there is only one case report associated with the intake of organophosphates. We present the case of a patient who presented with a clinical picture compatible with neuroleptic malignant syndrome, after the ingestion of an organophosphate (chlorpyrifos). A 57-year-old man who consulted for attempted suicide, acute deterioration of consciousness, torpid neurological evolution, and associated autonomic instability associated with rigidity, persistent hyperthermia, and elevated CPK. Bromocriptine treatment was offered, which resolved the clinical picture. The association with the ingestion of an organophosphate was established, and he was discharged without sequelae. The diagnosis of neuroleptic malignant syndrome is clinical and should be considered in any case of exposure to substances that may lead to dysregulation of dopaminergic neurotransmission in order to initiate timely therapy and impact outcomes.


El síndrome neuroléptico maligno es una condición clínica rara y potencialmente letal que frecuentemente se asocia con el uso de antipsicóticos. En la literatura especializada se encontró únicamente un reporte de caso relacionado con la ingestión de organofosforados. Se presenta un paciente con un cuadro clínico correspondiente al síndrome neuroléptico maligno posterior a la ingestión de clorpirifós. Como resultado de un intento de suicidio con el mencionado organofosforado, el hombre de 57 años presentó deterioro agudo del estado de consciencia, evolución neurológica tórpida e inestabilidad autonómica asociada a rigidez e hipertermia persistentes, así como incremento de la creatina-fosfocinasa (creatine phosphokinase, CPK). Se le administró tratamiento con bromocriptina, con lo cual el cuadro clínico remitió, y fue dado de alta sin secuelas. El diagnóstico del síndrome neuroléptico maligno es clínico y debe contemplarse en cualquier caso de exposición a sustancias que puedan resultar en una desregulación de la neurotransmisión dopaminérgica, con el fin de iniciar el tratamiento oportuno y contrarrestar efectivamente los efectos.


Assuntos
Antipsicóticos , Clorpirifos , Síndrome Maligna Neuroléptica , Intoxicação por Organofosfatos , Antipsicóticos/efeitos adversos , Bromocriptina/uso terapêutico , Clorpirifos/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Síndrome Maligna Neuroléptica/diagnóstico , Síndrome Maligna Neuroléptica/etiologia , Síndrome Maligna Neuroléptica/terapia , Intoxicação por Organofosfatos/complicações
2.
J Vet Pharmacol Ther ; 42(5): 548-555, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31328799

RESUMO

The combination of the organophosphate (OP) chlorpyrifos (CPF) and the pyrethroid cypermethrin (CPM) is commonly marketed as pour-on formulations for the control of sheep lice, ked, and blowflies. CPF irreversibly inhibits acetylcholinesterases (AChE), while pyrethroids are not AChE inhibitors. However, combinations of pyrethroids with OPs showed a highly synergistic effect on AChE inhibition. Thus, the aim of the current work was to evaluate in vitro and in vivo the inhibitory potency of both pesticides, alone and in combination with AChE and butyrylcholinesterase (BChE) activities in sheep blood. In vitro, IC50 values were similar after CPF or CPF plus CPM incubations. The pour-on coadministration of recommended doses of CPF and CPM did not cause a significant inhibition of AChE and BChE in sheep blood. Only slight percentages of inhibition of their catalytic activities were observed when both drugs were given at 4-fold higher dose rates. The lower systemic availability of topical administration of OPs in sheep may help to explain the lower degree of inhibition of blood AChE and BChE in vivo. The results emerged from this research are a further contribution to the knowledge of the risks of implementing higher dosage regimens of OPs-containing antiparasitic formulations.


Assuntos
Acetilcolinesterase/metabolismo , Butirilcolinesterase/metabolismo , Clorpirifos/efeitos adversos , Inibidores da Colinesterase/efeitos adversos , Piretrinas/efeitos adversos , Ovinos/sangue , Administração Tópica , Animais , Clorpirifos/administração & dosagem , Clorpirifos/uso terapêutico , Inibidores da Colinesterase/administração & dosagem , Inibidores da Colinesterase/uso terapêutico , Combinação de Medicamentos , Inseticidas/administração & dosagem , Inseticidas/efeitos adversos , Inseticidas/uso terapêutico , Masculino , Piretrinas/administração & dosagem , Piretrinas/uso terapêutico
3.
Vet Parasitol Reg Stud Reports ; 12: 43-48, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-31014808

RESUMO

The objective of this work was to evaluate the efficacy of two cypermethrin- and chlorpyrifos-based acaricides in controlling Rhipicephalus microplus in a naturally infested bovine herd and in in vitro tests, as well as to monitor the animals for tick fever. Male bovines in the rearing phase were used, with 30 Brangus and 30 Nellore animals naturally infested. The groups were composed as follows: 15 Nellore treated, 15 Nellore control, 15 Brangus treated and 15 Brangus control. Every 18 days, the animals were monitored for tick count, acaricide treatment, weight, blood pack cell volume, and clinical signs. For in vitro tests, the larval packet test, adult immersion test and DNA amplification for tick fever diagnosis were performed. In the first animal treatment period, product 1 (cypermethrin, 15 g + chlorpyrifos, 25 g + citronellal, 1 g) was used; in the second period, product 2 (cypermethrin, 15 g + chlorpyrifos, 30 g + fenthion, 15 g) was used. In Brangus animals, the mean efficacy was 35.1% and 95.8% in the first and second periods, respectively, for the same animals. For Nellore animals, the efficacy in periods one and two was 51% and 97.1%, respectively. The in vitro results showed efficacy above 95% for the two challenged acaricides. The Brangus animals showed a high production of ticks associated with the presence of tick fever agents, which could generate risks for the disease's enzootic stability.


Assuntos
Acaricidas/uso terapêutico , Doenças dos Bovinos/tratamento farmacológico , Clorpirifos/uso terapêutico , Piretrinas/uso terapêutico , Rhipicephalus/efeitos dos fármacos , Infestações por Carrapato/veterinária , Animais , Brasil , Bovinos , Masculino , Reação em Cadeia da Polimerase , Infestações por Carrapato/tratamento farmacológico
4.
Vet Parasitol ; 207(3-4): 302-8, 2015 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-25577676

RESUMO

The efficacy of the fungus Metarhizium anisopliae to control ticks has been shown in several in vitro experiments. However, few studies have been undertaken in field conditions in order to demonstrate the applicability of its use as a biological control of ticks and its combination with chemical acaricides. The aim of the present study was to evaluate the efficacy of M. anisopliae to control an acaricide-resistant strain of Rhipicephalus microplus under laboratory and field conditions. First, the compatibility of M. anisopliae strain (TIS-BR03) with commercial acaricides and its potential to control the cattle tick were evaluated in vitro. In general, acaricide treatments had mild effects on fungus viability. In the field experiment, the median of treatment efficacy with acaricide only, M. anisopliae only and combination of M. anisopliae with acaricide were 71.1%, 56.3% and 97.9%, respectively. There is no statistical difference between groups treated with M. anisopliae and acaricide alone. Thus, in this work we have demonstrated the applicability of M. anisopliae use associated or not with chemical acaricides on field conditions in order to control an acaricide-resistant strain of the cattle tick R. microplus.


Assuntos
Acaricidas/uso terapêutico , Doenças dos Bovinos/terapia , Resistência a Medicamentos , Metarhizium/fisiologia , Rhipicephalus/microbiologia , Controle de Ácaros e Carrapatos , Infestações por Carrapato/veterinária , Acaricidas/farmacologia , Animais , Bovinos , Doenças dos Bovinos/tratamento farmacológico , Clorpirifos/farmacologia , Clorpirifos/uso terapêutico , Feminino , Piretrinas/farmacologia , Piretrinas/uso terapêutico , Rhipicephalus/efeitos dos fármacos , Infestações por Carrapato/tratamento farmacológico , Infestações por Carrapato/terapia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA